Wolfe Research initiated coverage on Sarepta Therapeutics
$SRPT
Biotechnology: Pharmaceutical Preparations
Health Care
Wolfe Research initiated coverage of Sarepta Therapeutics with a rating of Peer Perform
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/18/2025 | $24.00 | Buy → Hold | TD Cowen |
| 6/17/2025 | Peer Perform | Wolfe Research | |
| 6/16/2025 | Overweight → Equal-Weight | Morgan Stanley | |
| 6/16/2025 | Overweight → Neutral | Cantor Fitzgerald | |
| 6/16/2025 | Buy → Neutral | BofA Securities | |
| 6/16/2025 | $70.00 | Outperform → Market Perform | BMO Capital Markets |
| 6/16/2025 | $36.00 | Overweight → Neutral | Piper Sandler |
| 6/16/2025 | $10.00 | Neutral → Sell | H.C. Wainwright |